Cargando…

Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro

Apolipoprotein (apo) mimetic peptides replicate some aspects of HDL function. We have previously reported the effects of compound ATI-5261 on its ability to replicate many functions of native apo A-I in the process of HDL biogenesis. ATI-5261 induced muscle toxicity in wild type C57Bl/6 mice, increa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hafiane, Anouar, Bielicki, John K., Johansson, Jan O., Genest, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514675/ https://www.ncbi.nlm.nih.gov/pubmed/26207756 http://dx.doi.org/10.1371/journal.pone.0131997

Ejemplares similares

Effect of the ABCA1 agonist CS-6253 on amyloid-β and lipoprotein metabolism in cynomolgus monkeys
por: Noveir, Sasan D., et al.
Publicado: (2022)

HDL, Atherosclerosis, and Emerging Therapies
por: Hafiane, Anouar, et al.
Publicado: (2013)

Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway
por: Pamir, Nathalie, et al.
Publicado: (2016)

Differential Effects of apoE4 and Activation of ABCA1 on Brain and Plasma Lipoproteins
por: Boehm-Cagan, Anat, et al.
Publicado: (2016)

ABCA1/ApoE/HDL Signaling Pathway Facilitates Myelination and Oligodendrogenesis after Stroke
por: Li, Li, et al.
Publicado: (2020)

In Vivo Inflammation Does Not Impair ABCA1-Mediated Cholesterol Efflux Capacity of HDL
por: Franssen, Remco, et al.
Publicado: (2012)

Will Lipidation of ApoA1 through Interaction with ABCA1 at the Intestinal Level Affect the Protective Functions of HDL?
por: Niesor, Eric J.
Publicado: (2015)

Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size
por: Kempen, Herman J., et al.
Publicado: (2014)

High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk
por: Hafiane, Anouar, et al.
Publicado: (2015)

ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity
por: Luo, Mengdie, et al.
Publicado: (2017)

Temporary sequestration of cholesterol and phosphatidylcholine within extracellular domains of ABCA1 during nascent HDL generation
por: Ishigami, Masato, et al.
Publicado: (2018)

The Effects of Rope Training on Lymphocyte ABCA1 Expression, Plasma ApoA-I and HDL-c in Boy Adolescents
por: Ghorbanian, Bahloul, et al.
Publicado: (2013)

A single infusion of MDCO-216 (ApoA-1 Milano/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease
por: Kallend, D.G., et al.
Publicado: (2016)

Combined LXR and RXR Agonist Therapy Increases ABCA1 Protein Expression and Enhances ApoAI-Mediated Cholesterol Efflux in Cultured Endothelial Cells
por: Huang, Kun, et al.
Publicado: (2021)

Hepatocyte ABCA1 deficiency is associated with reduced HDL sphingolipids
por: Othman, Alaa, et al.
Publicado: (2023)

ApoB and Non‐HDL Cholesterol Versus LDL Cholesterol for Ischemic Stroke Risk
por: Johannesen, Camilla D. L., et al.
Publicado: (2022)

Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo-deficient mice
por: Carter, Alexis Y., et al.
Publicado: (2017)

Neuroprotective efficacy of ABCA1 and HDL in aging rats with cerebrovascular hypoperfusion
por: Wang, Linhui, et al.
Publicado: (2012)

HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE(-/-) Mice: Evidence of ABCA1 Down-Regulation
por: Tardy, Claudine, et al.
Publicado: (2015)

Akt Inhibition Promotes ABCA1-Mediated Cholesterol Efflux to ApoA-I through Suppressing mTORC1
por: Dong, Fumin, et al.
Publicado: (2014)

Human paraoxonase 1 overexpression in mice stimulates HDL cholesterol efflux and reverse cholesterol transport
por: Ikhlef, Souade, et al.
Publicado: (2017)

Atrial Natriuretic Peptide Inhibited ABCA1/G1-dependent Cholesterol Efflux Related to Low HDL-C in Hypertensive Pregnant Patients
por: Dong, Yubing, et al.
Publicado: (2021)

HDL‐mediated reduction of cholesterol content inhibits the proliferation of prostate cancer cells induced by LDL: Role of ABCA1 and proteasome inhibition
por: Ossoli, Alice, et al.
Publicado: (2022)

HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
por: Chyu, Kuang-Yuh, et al.
Publicado: (2015)

Excessive exogenous cholesterol activating intestinal LXRα-ABCA1/G5/G8 signaling pathway can not reverse atherosclerosis in ApoE(−/−) mice
por: Yu, Xichao, et al.
Publicado: (2023)

Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux
por: Daniil, Georgios, et al.
Publicado: (2013)

HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis
por: Borja, Mark S., et al.
Publicado: (2013)

HIV hijacks cholesterol transporter ABCA1 to get access to cellular cholesterol
por: Bukrinsky, Michael, et al.
Publicado: (2009)

Correction: Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux
Publicado: (2014)

Thermogenic adipocytes promote HDL turnover and reverse cholesterol transport
por: Bartelt, Alexander, et al.
Publicado: (2017)

Suppression of liver Apo E secretion leads to HDL/cholesterol immaturity in rats administered ethinylestradiol
por: Yamaguchi, Kosuke, et al.
Publicado: (2016)

Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
por: Valanti, Eftaxia-Konstantina, et al.
Publicado: (2018)

Reverse Cholesterol Transport: Molecular Mechanisms and the Non-medical Approach to Enhance HDL Cholesterol
por: Marques, Leandro R., et al.
Publicado: (2018)

High-density lipoprotein metabolism and reverse cholesterol transport: strategies for raising HDL cholesterol
por: Trajkovska, Katerina Tosheska, et al.
Publicado: (2017)

High HDL-Cholesterol Paradox: SCARB1-LAG3-HDL Axis
por: Rodriguez, Annabelle
Publicado: (2021)

Biomedical Advances in ABCA1 Transporter: From Bench to Bedside
por: Choi, Hong Y., et al.
Publicado: (2023)

Adrenal Function in Females with Low Plasma HDL-C Due to Mutations in ABCA1 and LCAT
por: Bochem, Andrea E., et al.
Publicado: (2014)

Hepatic ACAT2 Knock Down Increases ABCA1 and Modifies HDL Metabolism in Mice
por: Pedrelli, Matteo, et al.
Publicado: (2014)

Exposure to High Glucose Concentration Decreases Cell Surface ABCA1 and HDL Biogenesis in Hepatocytes
por: Tsujita, Maki, et al.
Publicado: (2017)

Allele-specific enhancers mediate associations between LCAT and ABCA1 polymorphisms and HDL metabolism
por: Howard, Alicia D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qnnnha1irl463j1uptsvtb1bkn